Eastman Chemical (NYSE:EMN) Given Average Rating of “Moderate Buy” by Analysts

Shares of Eastman Chemical (NYSE:EMNGet Free Report) have received an average recommendation of “Moderate Buy” from the fourteen analysts that are covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $97.81.

Several equities analysts have recently issued reports on EMN shares. Wells Fargo & Company lifted their price target on Eastman Chemical from $89.00 to $100.00 and gave the company an “equal weight” rating in a research report on Thursday, April 11th. Redburn Atlantic assumed coverage on shares of Eastman Chemical in a research report on Thursday, February 15th. They issued a “buy” rating and a $110.00 price target on the stock. Citigroup raised their price objective on shares of Eastman Chemical from $95.00 to $114.00 and gave the company a “buy” rating in a research report on Wednesday, April 10th. UBS Group boosted their target price on shares of Eastman Chemical from $91.00 to $93.00 and gave the stock a “neutral” rating in a report on Friday, February 2nd. Finally, Stifel Nicolaus reduced their target price on shares of Eastman Chemical from $102.00 to $101.00 and set a “buy” rating for the company in a report on Monday, February 5th.

Get Our Latest Report on EMN

Eastman Chemical Stock Performance

EMN stock opened at $96.12 on Friday. The company has a market capitalization of $11.30 billion, a P/E ratio of 12.83, a PEG ratio of 1.07 and a beta of 1.54. The company has a quick ratio of 0.70, a current ratio of 1.35 and a debt-to-equity ratio of 0.78. The company has a 50-day simple moving average of $93.56 and a 200 day simple moving average of $86.16. Eastman Chemical has a fifty-two week low of $68.89 and a fifty-two week high of $102.71.

Eastman Chemical (NYSE:EMNGet Free Report) last issued its quarterly earnings results on Friday, February 2nd. The basic materials company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.03. Eastman Chemical had a net margin of 9.71% and a return on equity of 14.15%. The company had revenue of $2.21 billion during the quarter, compared to analyst estimates of $2.21 billion. During the same period in the prior year, the business posted $0.89 EPS. The business’s revenue for the quarter was down 7.0% compared to the same quarter last year. Sell-side analysts predict that Eastman Chemical will post 7.71 earnings per share for the current fiscal year.

Eastman Chemical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 5th. Investors of record on Friday, March 15th were paid a $0.81 dividend. This represents a $3.24 annualized dividend and a yield of 3.37%. The ex-dividend date was Thursday, March 14th. Eastman Chemical’s dividend payout ratio is currently 43.26%.

Insider Buying and Selling at Eastman Chemical

In other news, SVP Adrian James Holt sold 4,735 shares of the stock in a transaction that occurred on Wednesday, March 6th. The shares were sold at an average price of $87.75, for a total value of $415,496.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.93% of the company’s stock.

Institutional Investors Weigh In On Eastman Chemical

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in shares of Eastman Chemical in the fourth quarter worth $121,847,000. Invesco Ltd. raised its stake in shares of Eastman Chemical by 37.4% during the 3rd quarter. Invesco Ltd. now owns 2,795,824 shares of the basic materials company’s stock worth $214,496,000 after purchasing an additional 760,974 shares in the last quarter. Capital Research Global Investors acquired a new stake in shares of Eastman Chemical during the 4th quarter valued at about $54,047,000. Mackenzie Financial Corp grew its stake in shares of Eastman Chemical by 274.5% in the 4th quarter. Mackenzie Financial Corp now owns 249,104 shares of the basic materials company’s stock valued at $22,375,000 after buying an additional 391,848 shares in the last quarter. Finally, Schonfeld Strategic Advisors LLC increased its holdings in Eastman Chemical by 1,031.0% in the third quarter. Schonfeld Strategic Advisors LLC now owns 333,655 shares of the basic materials company’s stock worth $25,598,000 after buying an additional 304,155 shares during the last quarter. Hedge funds and other institutional investors own 83.65% of the company’s stock.

About Eastman Chemical

(Get Free Report

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Further Reading

Analyst Recommendations for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.